Breaking News Instant updates and real-time market news.

RVLV

Revolve Group

$24.40

-1.35 (-5.24%)

14:45
09/12/19
09/12
14:45
09/12/19
14:45

Revolve Group call volume above normal and directionally bullish

Bullish option flow detected in Revolve Group with 3,034 calls trading, 2x expected, and implied vol increasing over 6 points to 72.68%. Sep-19 22.5 calls and Sep-19 25 calls are the most active options, with total volume in those strikes near 2,200 contracts. The Put/Call Ratio is 0.11. Earnings are expected on November 11th.

RVLV Revolve Group
$24.40

-1.35 (-5.24%)

07/02/19
WBLR
07/02/19
INITIATION
WBLR
Outperform
Revolve Group initiated with an Outperform at William Blair
William Blair analyst Ralph Schackart initiated coverage of Revolve Group (RVLV) with an Outperform rating. The analyst believes Revolve's value proposition to female, fashion-focused millennial shoppers is inherently different from that of Amazon's (AMZN) offerings. She believes Revolve has "several upside opportunities" to augment its business model and increase its share of the global online apparel.
07/02/19
GUGG
07/02/19
INITIATION
Target $50
GUGG
Buy
Guggenheim starts Revolve Group at Buy with $50 price target
As previously reported, Guggenheim analyst Robert Drbul initiated Revolve Group with a Buy rating and $50 price target. Active customers have doubled since 2015 to over 1.26M in Q1 and he expects continued strong growth in the low 20% range in 2019/2020, noted Drbul, who also noted that the company has been profitable in 15 years of its 16 year history.
07/02/19
JEFF
07/02/19
INITIATION
Target $60
JEFF
Buy
Revolve Group initiated with a Buy at Jefferies
Jefferies analyst Randal Konik started Revolve Group with a Buy rating and $60 price target. Revolve is the future of retail and brand marketing with its digital commerce platform built on a data-driven backbone and an "enviable" influencer ecosystem, Konik tells investors in a research note. He believes the company's growth and market share gains are the "first inning."
08/09/19
JEFF
08/09/19
NO CHANGE
Target $65
JEFF
Buy
Revolve Group price target raised to $65 from $60 at Jefferies
Jefferies analyst Randal Konik raised his price target for Revolve Group to $65 from $60 saying the company's Q2 results illustrate "robust" growth in active customers and orders, while its margins continue to rise. The quarter highlights the power of the Revolve platform to both aggregate consumers and influencers and scale profits, Konik tells investors in a research note. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

AZN

AstraZeneca

$43.80

-0.41 (-0.93%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Hot Stocks
AstraZeneca says trastuzumab deruxtecan granted FDA Priority Review »

AstraZeneca and Daiichi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

POOL

Pool Corp.

$200.56

-4.63 (-2.26%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Earnings
Pool Corp. reports Q3 EPS ex-items $1.84, consensus $1.78 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

TXMD

TherapeuticsMD

$3.70

-0.22 (-5.61%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Initiation
TherapeuticsMD initiated  »

TherapeuticsMD initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$79.12

0.8 (1.02%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Earnings
Philip Morris lowers FY19 EPS view to 'at least $4.73' from 'at least $4.94' »

Consensus $5.21. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Recommendations
Netflix analyst commentary  »

KeyBanc lowers estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NBRV

Nabriva Therapeutics

$2.01

0.08 (4.15%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Conference/Events
Nabriva Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

BBIO

BridgeBio

$17.92

-0.6 (-3.24%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Hot Stocks
BridgeBio reports preclinical data on infigratinib in treating achondroplasia »

BridgeBio Pharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.28

-1.37 (-0.67%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Initiation
Amgen initiated  »

Amgen reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

UCBJY

UCB

$0.00

(0.00%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Hot Stocks
UCB says bimekizumab Phase 3 psoriasis study meets all endpoints »

UCB announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SASR

Sandy Spring Bancorp

$33.42

0.21 (0.63%)

07:04
10/17/19
10/17
07:04
10/17/19
07:04
Earnings
Sandy Spring Bancorp reports Q3 EPS 82c, consensus 80c »

"In the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AUG

Auryn Resources

$1.28

0.09 (7.56%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Hot Stocks
Auryn Resources stakes additional claims at Sombrero North project area »

Auryn Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$45.53

0.33 (0.73%)

, WBA

Walgreens Boots Alliance

$54.66

0.15 (0.28%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Hot Stocks
Centene, Walgreens Boots Alliance, RxAdvance announce partnership »

Centene (CNC), Walgreens…

CNC

Centene

$45.53

0.33 (0.73%)

WBA

Walgreens Boots Alliance

$54.66

0.15 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

MIST

Milestone Pharmaceuticals

$18.75

0.25 (1.35%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Conference/Events
Milestone Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PM

Philip Morris

$79.12

0.8 (1.02%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Earnings
Philip Morris reports Q3 adjusted EPS $1.43, consensus $1.36 »

Reports Q3 net revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

MDGL

Madrigal Pharmaceuticals

$86.78

-0.49 (-0.56%)

07:00
10/17/19
10/17
07:00
10/17/19
07:00
Conference/Events
Madrigal Pharmaceuticals management to meet with Oppenheimer »

Luncheon Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ALXN

Alexion

$99.41

-5.435 (-5.18%)

06:58
10/17/19
10/17
06:58
10/17/19
06:58
Initiation
Alexion initiated  »

Alexion reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

PPG

PPG

$118.89

0.665 (0.56%)

06:58
10/17/19
10/17
06:58
10/17/19
06:58
Hot Stocks
PPG CEO says 'we made excellent progress executing on our key initiatives' »

"We delivered strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

MNST

Monster Beverage

$56.54

0.27 (0.48%)

06:57
10/17/19
10/17
06:57
10/17/19
06:57
Downgrade
Monster Beverage rating change  »

Monster Beverage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULC

Fulcrum Therapeutics

$4.71

-0.15 (-3.09%)

06:57
10/17/19
10/17
06:57
10/17/19
06:57
Conference/Events
Fulcrum Therapeutics management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

TSN

Tyson Foods

$81.87

-1.85 (-2.21%)

06:57
10/17/19
10/17
06:57
10/17/19
06:57
Hot Stocks
Tyson Fresh Meats to prohibit ractopamine use »

In an effort to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

GPRK

GeoPark

$17.95

-0.18 (-0.99%)

06:56
10/17/19
10/17
06:56
10/17/19
06:56
Hot Stocks
GeoPark reports Q3 operational results »

GeoPark reported an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDX

Ardelyx

$4.34

-0.05 (-1.14%)

06:55
10/17/19
10/17
06:55
10/17/19
06:55
Conference/Events
Ardelyx to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PPG

PPG

$118.89

0.665 (0.56%)

06:54
10/17/19
10/17
06:54
10/17/19
06:54
Earnings
PPG sees FY19 adjusted EPS $6.17-$6.27, consensus $6.24 »

"As we look ahead to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SAM

Boston Beer

06:53
10/17/19
10/17
06:53
10/17/19
06:53
Upgrade
Boston Beer rating change  »

Cowen upgrades Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

PPG

PPG

$118.89

0.665 (0.56%)

06:52
10/17/19
10/17
06:52
10/17/19
06:52
Earnings
PPG reports Q3 adjusted EPS $1.67, consensus $1.61 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.